28th Jun 2021 12:04
Cambridge Cognition Holdings PLC - Cambridge, England-based digital neuroscience company - Announces new GBP2.2 million contract for at-home cognitive testing in a virtual clinical trial. Says revenue expected to be recognised by the company over three years beginning in the second half of 2021.
Chief Executive Matthew Stork said: "As widely predicted, the Covid-19 pandemic has accelerated interest in virtual clinical trial assessments and Cambridge Cognition is well positioned to benefit from the consequent substantial growth opportunities. We are pleased to have secured another large contract for a virtual clinical trial where we will be working with a leading pharmaceutical company in the sector."
Current stock price: 162.10 pence, up 18% at midday in London
By Greg Roxburgh; [email protected]
Copyright 2021 Alliance News Limited. All Rights Reserved.
Related Shares:
Cambridge Cog